ESC 365 - Comparison of effectiveness, safety, and healthcare costs in non-valvular atrial fibrillation patients with heart failure prescribed direct oral anticoagulants

ESC Premium Access

Comparison of effectiveness, safety, and healthcare costs in non-valvular atrial fibrillation patients with heart failure prescribed direct oral anticoagulants

Session: Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome 2

Topic: Heart Failure in Atrial Fibrillation

Speaker: Miss A. Bassalobre Garcia (Morrisville, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Miss Alessandra Bassalobre Garcia

Morrisville (United States of America)

0 follower

8 more presentations in this session

Elevated biomarkers are associated with increased risk of death and heart failure hospitalization in patients with atrial fibrillation: insights from the ARISTOTLE trial

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Relationship between diabetes mellitus and a risk of heart failure hospitalization in patients with atrial fibrillation: the Fushimi AF registry

Speaker: Doctor M. Ishii (Kyoto, JP)

Relationship between structural brain damage and cognitive function in patients with atrial fibrillation

Speaker: Doctor S. Aeschbacher (Basel, CH)

Physical activity and outcome in patients with atrial fibrillation

Speaker: Doctor R. Brenner (St. Gallen, CH)

Long-term clinical impact of sinus rhythm restoration in atrial fibrillation patients with heart failure with mid-ranged ejection fraction

Speaker: Associate Professor Y. Baek (Incheon, KR)

Access the full session

Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome 2

Speakers: Miss A. Bassalobre Garcia, Associate Professor Z. Hijazi, Doctor M. Ishii, Doctor S. Aeschbacher, Doctor R. Brenner...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources